All In Biotech

Drug Trial Radar · NCT07216313

A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants

A Phase 1, Open-Label Study to Evaluate the Mutual Drug-Drug Interaction Potential Between Denifanstat and Resmetirom in Healthy Adult Participants

Last checked: Nov 19, 2026Latest source record: Jan 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Sep 30, 2025

Primary completion

Oct 20, 2025

Study completion Oct 20, 2025

Sponsor

Lead sponsor
Sagimet Biosciences Inc.Industry
Sponsor type
Industry
First posted
Oct 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.

Conditions

  • Healthy

Interventions

  • DenifanstatDrug

    Once daily

  • ResmetiromDrug

    Once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the concentration-time curve during a dosing interval (tau) at steady state (AUC0-tau)Time frame: 7 days
  2. Maximum observed concentration at steady-state (Cmax,ss)Time frame: 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Celerion

    Tempe, Arizona

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.